Objective: To quantify the effects of cognitive training (CT) on cognitive and behavioral
outcome measures in patients with Parkinson disease (PD). Methods: We systematically …

Physical and cognitive exercise may prevent or delay dementia in later life but the neural
mechanisms underlying these therapeutic benefits are largely unknown. We examined …

We describe a de novo computational approach for designing proteins that recapitulate the
binding sites of natural cytokines, but are otherwise unrelated in topology or amino acid …

The therapeutic potential of recombinant cytokines has been limited by the severe side effects
of systemic administration. We describe a strategy to reduce the dose-limiting toxicities of …

Background. Cognitive impairments are common in people with multiple sclerosis (MS).
Systematic reviews reported promising evidence for various cognitive interventions in this …

Introduction Exercise is recognized as a modifiable lifestyle factor that can mitigate cognitive
decline and dementia risk. While the benefits of exercise on cognitive aging have been …

Cognitive impairment is a central non-motor symptom of Parkinson’s disease (PD), and
there are no established treatments. Computerized cognitive training (CCT) is a safe and …

Chimeric antigen receptor (CAR)–modified T cell therapy is effective in treating lymphomas,
leukemias, and multiple myeloma in which the tumor cells express high amounts of target …

The increased understanding that neuropathology begins decades before symptom onset,
has led to the conceptualization and widespread utilization of Mild Cognitive Impairment (MCI…

Adoptive transfer of T cells expressing chimeric antigen receptors (CAR-T) effectively treats
refractory hematologic malignancies in a subset of patients but can be limited by poor T-cell …